SCOTT GELLER: Open Payments
NPI 1033661368 · RYDAL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 33 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $3,326 · 2025 $876
Food & beverage: $876
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $214 |
| Janssen Scientific Affairs, LLC | 2 | $202 |
| Janssen Biotech, Inc. | 6 | $141 |
| Madrigal Pharmaceuticals | 2 | $90 |
| PFIZER INC. | 3 | $57 |
| Amgen Inc. | 2 | $40 |
| GENZYME CORPORATION | 1 | $29 |
| Novo Nordisk Inc | 1 | $28 |
| Lilly USA, LLC | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
Products named: TREMFYA, LINZESS, REZDIFFRA, XELJANZ, SKYRIZI, UPLIZNA, MAVYRET, RINVOQ.
Industry payments across PA — which companies pay providers there.
